Transcytosis of nanoparticle and dendrimer delivery systems: evolving vistas.
about
Nanoparticles - known and unknown health risksDrug Carrier for Photodynamic Cancer TherapyMitoxantrone-Surfactant Interactions: A Physicochemical OverviewGastrointestinal biodurability of engineered nanoparticles: Development of an in vitro assayEx-vivo evaluation of alginate microparticles for Polymyxin B oral administration.Changes produced by external radiation in parameters influencing intestinal permeability and microparticle uptake in vitro.Targeted Therapy of Cancer Using Photodynamic Therapy in Combination with Multi-faceted Anti-Tumor ModalitiesPoly(ethylene oxide)-modified poly(beta-amino ester) nanoparticles as a pH-sensitive system for tumor-targeted delivery of hydrophobic drugs: part 2. In vivo distribution and tumor localization studiesTargeting approaches to oral drug delivery.Toxic effects of repeated oral exposure of silver nanoparticles on small intestine mucosa of mice.Oral Delivery of DMAB-Modified Docetaxel-Loaded PLGA-TPGS Nanoparticles for Cancer Chemotherapy.Biodistribution of PLGA and PLGA/chitosan nanoparticles after repeat-dose oral delivery in F344 rats for 7 daysSilencing β3 Integrin by Targeted ECO/siRNA Nanoparticles Inhibits EMT and Metastasis of Triple-Negative Breast Cancer.Issues in oral nanoparticle drug carrier uptake and targeting.Use of targeting agents to increase uptake and localization of drugs to the intestinal epithelium.Novel drug delivery system based on docetaxel-loaded nanocapsules as a therapeutic strategy against breast cancer cellsPast, present, and future technologies for oral delivery of therapeutic proteins.The potential advantages of nanoparticle drug delivery systems in chemotherapy of tuberculosis.Drug delivery systems: An updated reviewBioadhesive properties of pegylated nanoparticles.The performance of nanocarriers for transmucosal drug delivery.Nanotechnology safety concerns revisited.Nanovehicular intracellular delivery systems.Biopharmaceutics and therapeutic potential of engineered nanomaterials.Engineering strategies to enhance nanoparticle-mediated oral delivery.Nanoparticles as protein and gene carriers to mucosal surfaces.Nanoparticle Formulation Increases Oral Bioavailability of Poorly Soluble Drugs: Approaches Experimental Evidences and TheoryAqueous self-assembly of poly(ethylene oxide)-block-poly(ε-caprolactone) (PEO-b-PCL) copolymers: disparate diblock copolymer compositions give rise to nano- and meso-scale bilayered vesiclesChitosan nanoparticles for drug delivery to the eye.Fabrication and in vitro/in vivo evaluation of amorphous andrographolide nanosuspensions stabilized by d-α-tocopheryl polyethylene glycol 1000 succinate/sodium lauryl sulfateNanoparticulate drug delivery systems for cancer chemotherapy.Designing dendrimers for drug delivery and imaging: pharmacokinetic considerations.Mechanistic enhancement of the intestinal absorption of drugs containing the polar guanidino functionality.Cellular uptake, intracellular trafficking, and cytotoxicity of nanomaterials.Nanoparticle delivery of anti-tuberculosis chemotherapy as a potential mediator against drug-resistant tuberculosis.Advances in the understanding of retinal drug disposition and the role of blood-ocular barrier transporters.Oral delivery of therapeutic proteins and peptides: a review on recent developments.Nanoemulsion-based oral delivery systems for lipophilic bioactive components: nutraceuticals and pharmaceuticals.Lipid polymer hybrid as emerging tool in nanocarriers for oral drug delivery.Nanotechnology Approaches for the Delivery of Exogenous siRNA for HIV Therapy.
P2860
Q24557518-F443A290-AE1E-4156-BA72-42A871A058E5Q26782780-EDC4532D-D29F-47CC-AE8A-121D1E740981Q28066259-4BBBF8A3-782D-454C-9A9F-D96015369501Q30431391-AC12D2B9-312E-4BF3-ADCD-20509689E36DQ33262949-DE8C47DA-4E2F-4483-B8DA-CB6573C0B65BQ33333563-6E2C279E-9B39-4411-85F3-077788395DE6Q33664307-38239412-99EF-45E1-B820-53ADDF48CC70Q34312572-6FA559E2-5646-464B-B742-6122C78BB3D0Q34482068-04070B82-021D-4BD0-8032-FF482752EF63Q34542728-4BE6059B-12BD-4A46-9C12-6F4FDD2B3DBFQ35008164-A5090669-76D0-4A1E-AE74-16815B8BFB8CQ35672475-6FCFEBD4-C5C3-46CF-83ED-17F125F2939CQ35674830-329DA15A-F5D3-4459-B005-6601D688C228Q35809222-5F63C48E-D68F-4223-B5A3-5DC619DB77A3Q35809229-EA9A4ECC-719A-4D6D-B2FE-E18C0CF900F0Q35934052-ED04B27B-325F-46C9-97A9-0F4EDBE04AC1Q36232650-80E6907A-0337-423A-873D-56E490AB441FQ36252799-8D7F24D9-8A47-47DE-B244-C5896E71498DQ36300205-5CE22CCC-8B62-41DC-9B4E-6F607F6E6824Q36316693-749279EB-D0F4-4591-9483-21CF77D3FEF6Q36527739-1B7BA3FB-E901-41DA-8FBA-844A8B2CDE47Q36865560-514B272F-E61B-47FA-B959-2B2C0503BEA0Q37058812-6876826E-D27B-4F0E-A423-5B1FB196B5CFQ37273411-A1135D38-4E91-4650-8C38-D6C57F69EADBQ37328673-B64969E6-7E18-4DB3-8858-3A3A893132AEQ37331802-CCA462D9-37D8-49F9-A2F9-D3F35A983DFFQ37401107-79FC8597-F9B4-44D4-BE50-A7E45363B8CFQ37403127-D20E24D4-07F0-4FB8-948E-6C2A30593EEDQ37416144-D0722754-15D7-438A-A58F-D82FFBC97714Q37638743-7144E7B0-2DF9-4096-BBB9-5372AE0892D7Q37799616-29B531E5-EB32-43B9-9F74-2016B3D5B483Q37823446-5B2CA170-E0E4-4DF4-8693-0DDC6C693B2AQ37828505-C23E0C66-D483-4E15-A508-6E6124B54497Q37869062-C38AD38F-5370-4906-A739-6676BFCC43E9Q37969743-5D177242-7DE7-4BF5-AD79-441738865F25Q38104396-8D05342D-749C-4B23-9A90-A03C71D3B9C7Q38122734-038ED9EF-4F9C-499A-8B41-4CE83506A382Q38123857-D963DB6E-BE1E-4638-BB89-5C2564FDE85DQ38252593-187A4AAA-8217-404F-A870-576721AC3D7CQ38622404-B1E759A9-0535-4D4C-9769-6BB4A4E132BC
P2860
Transcytosis of nanoparticle and dendrimer delivery systems: evolving vistas.
description
2001 nî lūn-bûn
@nan
2001 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Transcytosis of nanoparticle and dendrimer delivery systems: evolving vistas.
@ast
Transcytosis of nanoparticle and dendrimer delivery systems: evolving vistas.
@en
Transcytosis of nanoparticle and dendrimer delivery systems: evolving vistas.
@nl
type
label
Transcytosis of nanoparticle and dendrimer delivery systems: evolving vistas.
@ast
Transcytosis of nanoparticle and dendrimer delivery systems: evolving vistas.
@en
Transcytosis of nanoparticle and dendrimer delivery systems: evolving vistas.
@nl
prefLabel
Transcytosis of nanoparticle and dendrimer delivery systems: evolving vistas.
@ast
Transcytosis of nanoparticle and dendrimer delivery systems: evolving vistas.
@en
Transcytosis of nanoparticle and dendrimer delivery systems: evolving vistas.
@nl
P1476
Transcytosis of nanoparticle and dendrimer delivery systems: evolving vistas.
@en
P2093
Florence AT
P304
P356
10.1016/S0169-409X(01)00184-3
P407
P478
50 Suppl 1
P577
2001-10-01T00:00:00Z